Published in Am J Physiol Cell Physiol on June 30, 2010
Intratubular renin-angiotensin system in hypertension. Hypertension (2011) 2.14
Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol (2011) 1.58
Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J (2012) 1.08
Tumor necrosis factor-α: regulation of renal function and blood pressure. Am J Physiol Renal Physiol (2013) 1.05
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch (2012) 0.99
Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells. J Biol Chem (2011) 0.97
Double plant homeodomain (PHD) finger proteins DPF3a and -3b are required as transcriptional co-activators in SWI/SNF complex-dependent activation of NF-κB RelA/p50 heterodimer. J Biol Chem (2012) 0.95
Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol (2013) 0.92
Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. Am J Physiol Heart Circ Physiol (2014) 0.88
Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension (2011) 0.87
Proximal tubule angiotensinogen modulation of arterial pressure. Curr Opin Nephrol Hypertens (2013) 0.85
Angiotensin II blockade and renal protection. Curr Pharm Des (2013) 0.85
Nuclear factor κB mediates suppression of canonical transient receptor potential 6 expression by reactive oxygen species and protein kinase C in kidney cells. J Biol Chem (2013) 0.83
Renal angiotensin-converting enzyme and blood pressure control. Curr Opin Nephrol Hypertens (2014) 0.81
JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation. JAKSTAT (2012) 0.81
Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart? Ochsner J (2013) 0.80
ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol (2014) 0.79
Microbial Degradation of Cellular Kinases Impairs Innate Immune Signaling and Paracrine TNFα Responses. Sci Rep (2016) 0.76
Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells. BMC Nephrol (2015) 0.76
Tumor necrosis factor-{alpha}: a reno-protective cytokine? Focus on "Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells". Am J Physiol Cell Physiol (2010) 0.76
Macrophage-derived IL-6 contributes to ANG II-mediated angiotensinogen stimulation in renal proximal tubular cells. Am J Physiol Renal Physiol (2016) 0.75
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol (2004) 7.23
New regulators of NF-kappaB in inflammation. Nat Rev Immunol (2008) 5.79
IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem (1999) 5.16
TNF-mediated inflammatory disease. J Pathol (2008) 5.00
Regulation of intrarenal angiotensin II in hypertension. Hypertension (2002) 3.34
Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol (2001) 3.23
TNF receptor subtype signalling: differences and cellular consequences. Cell Signal (2002) 2.57
Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol (2005) 2.30
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest (1990) 2.29
Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol (1992) 2.20
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol (2008) 2.15
Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol (2007) 1.99
Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol (2007) 1.87
PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int (1993) 1.86
betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol Cell Biol (2003) 1.69
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl (2002) 1.65
TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J (2005) 1.60
Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab (2004) 1.51
Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci Signal (2008) 1.38
Advances in targeting IKK and IKK-related kinases for cancer therapy. Clin Cancer Res (2008) 1.37
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol (2008) 1.37
DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J Biol Chem (2005) 1.34
Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol (2008) 1.24
The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem (2004) 1.23
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis (2006) 1.15
Tumor necrosis factor-alpha induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol (2008) 1.08
IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol (2009) 1.03
Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats. Dig Dis Sci (2004) 1.02
NF-kappaB signalling in chronic kidney disease. Front Biosci (Landmark Ed) (2009) 1.01
NF-kappaB and inflammation in genetic disease. Biochem Pharmacol (2006) 0.98
Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation (2003) 0.96
Effect of BSA-induced ER stress on SGLT protein expression levels and alpha-MG uptake in renal proximal tubule cells. Am J Physiol Renal Physiol (2009) 0.90
Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats. Hypertension (1997) 0.85
Reduced progression of adriamycin nephropathy in spontaneously hypertensive rats treated by losartan. Nephrol Dial Transplant (2008) 0.85
Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus. J Hum Hypertens (2007) 0.83
TNF-alpha deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction. Exp Mol Pathol (2008) 0.82
Transcriptional regulation of angiotensinogen gene expression. Vitam Horm (1999) 0.82
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Regulation of intrarenal angiotensin II in hypertension. Hypertension (2002) 3.34
Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int (2002) 3.23
Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension (2003) 2.99
AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension (2004) 2.86
Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol (2012) 2.58
Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension (2004) 2.54
The absence of intrarenal ACE protects against hypertension. J Clin Invest (2013) 2.31
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol (2005) 2.25
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol (2008) 2.15
Intratubular renin-angiotensin system in hypertension. Hypertension (2011) 2.14
Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension (2002) 2.11
Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension (2008) 2.01
Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol (2007) 1.99
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice. Am J Physiol Renal Physiol (2007) 1.99
Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension (2003) 1.89
Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol (2007) 1.87
AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol (2005) 1.84
Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice. Hypertension (2009) 1.83
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol (2006) 1.83
Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension (2002) 1.82
ATP mediates tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol (2002) 1.78
Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant (2012) 1.75
Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol (2009) 1.75
Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension (2004) 1.72
Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways. Hypertens Res (2010) 1.71
Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats. Hypertension (2010) 1.67
Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol (2009) 1.64
Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens (2010) 1.60
Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol (2002) 1.59
Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol (2011) 1.58
Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun (2007) 1.52
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension (2013) 1.52
Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res (2009) 1.51
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease. Hypertens Res (2012) 1.50
Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol (2012) 1.48
Heme oxygenase induction attenuates afferent arteriolar autoregulatory responses. Am J Physiol Renal Physiol (2008) 1.48
Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens (2006) 1.46
Augmented cyclooxygenase-2 effects on renal function during varying states of angiotensin II. Am J Physiol Renal Physiol (2010) 1.45
Intracellular ANG II induces cytosolic Ca2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells. Am J Physiol Renal Physiol (2005) 1.45
Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci (2009) 1.43
Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells. Am J Hypertens (2011) 1.43
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol (2008) 1.37
Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol (2008) 1.34
Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol (2008) 1.34
Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats. Am J Physiol Renal Physiol (2009) 1.33
Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant (2010) 1.32
Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol (2009) 1.30
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant (2010) 1.29
Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am J Physiol Renal Physiol (2011) 1.27
Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int J Biol Sci (2006) 1.27
Enhanced superoxide generation modulates renal function in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol (2005) 1.27
AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: role of cytoskeleton microtubules and tyrosine phosphatases. Am J Physiol Renal Physiol (2006) 1.27
Angiotensin II stimulates renin in inner medullary collecting duct cells via protein kinase C and independent of epithelial sodium channel and mineralocorticoid receptor activity. Hypertension (2011) 1.25
Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol (2002) 1.24
Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens (2010) 1.22
Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension (2008) 1.20
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int (2004) 1.20
Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy. Biomark Insights (2009) 1.17
ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function. PLoS One (2011) 1.16
Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol (2007) 1.16
Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension (2002) 1.15
Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol (2006) 1.15
Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens (2010) 1.14
Involvement of the brain (pro)renin receptor in cardiovascular homeostasis. Circ Res (2010) 1.14
Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension. J Hypertens (2003) 1.14
Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation (2012) 1.13
Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion. J Am Soc Nephrol (2010) 1.13